Multi-Institutional Collaborative Study for Estimating the Persistence of Treatment Free Remission in Chronic Myeloid Leukemia after Stopping Tyrosine Kinase Inhibitor in Japa
Not Applicable
Recruiting
- Conditions
- CML (chronic myeloid leukemia)
- Registration Number
- JPRN-UMIN000037535
- Lead Sponsor
- THE JAPANESE SOCIETY OF HEMATOLOGY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who can not provide clinical information and data before and after stopping TKI or after re-treatment by TKI 2) Other, patients whom the investigator considers to be unsuitable for participation in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TFR rate at 5-years after stopping TKI
- Secondary Outcome Measures
Name Time Method TFR rate at 10-years after stopping TKI Estimated Treatment Free Survival (TFS) or Progression Free Survival (PFS) to AP or BC after stopping TKI Cumulative Re-MMR rate after retreatment with TKI in patients who lost TFR